Background
Introduction
Type 2 diabetes (T2DM) affects over 316 million people worldwide and is expected to rise to 552 million by 2030. [1] It is associated with high morbidity, mortality and healthcare costs. [2] Screening for diabetes is feasible and identifies people with modifiable cardiovascular risk. [3] Increasing global prevalence of people at high risk of diabetes [4] supports a case for early detection and initiation of treatment of T2DM to prevent a high incidence of mortality and morbidity. Screening for both diabetes and those at high risk followed by lifestyle interventions has been suggested as being cost-effective [5, 6] and may reduce long term complications. [6, 7] T2DM certainly meets many of the screening criteria. [8] There is evidence that screening for diabetes has an overall benefit [6] with no harm to patients. [9] Many international organisations [2, 6, 7, 10] have produced guidelines on screening for T2DM with information on screening tests and populations, yet none have made major recommendations regarding the strategies to approach screening and the method of invitation.
There are a number of tests available for screening and diagnosing people with T2DM and those at high risk of diabetes. One of the widely used methods is the oral glucose tolerance test (OGTT). [4] However, other methods have also been suggested such as fasting plasma glucose, [7] and non-invasive risk scores such as the FINDRISC. [11] Recently glycated haemoglobin (HbA1c) has been suggested as a diagnostic tool by WHO [4] but it is still not universally standardized and many countries still recommend using OGTT. [4] NICE Guidance suggests the use of various non-invasive screening tools followed by the use of diagnostic blood tests for identifying those with diabetes or at high risk [6] . Cost, pragmatic problems in installation of a new test, and higher prevalence of conditions such as haemoglobinopathies which undermine the accuracy of HbA1c results are barriers to use this test in some developing countries. [12] [13] [14] [15] A number of studies have reported various combinations of methods of screening including the use of risk scores which help in targeted screening followed by an OGTT. [16, 17] These risk score assessments are either patient led [11] or computer generated from general practice records. [18, 19] However, there has been some uncertainty about the uptake of diabetes screening programmes in the real world setting. [20] Evidence on response to medical screening invitations has varied depending on a number of factors including the level of social deprivation [21] , information on the severity of the disease, possible benefits of screening [22] , the information provided [23] , and levels of anxiety. [24, 25] Questions still remain about how screening should be performed, in terms of producing the highest response rate and diagnostic yield.
Our objective was to perform a systematic review and meta-analysis of responses to different methods of screening and their diagnostic yield using OGTT as an example of a definite diagnostic test. We also sought to assess the effect of the countries developmental status, invitation type, locality and whether an invasive or non-invasive initial test was included on these outcomes.
Methods
A systematic review was conducted to identify published articles on screening for T2DM. We searched Medline, Embase and Cochrane online databases (1998-March/2015) using the headings of 'Diabetes', 'Pre Ã diabet Ã ', "Glycemia', 'Impaired glucose tolerance', 'Impaired fasting', 'Screening', etc. (Search strategies are included in the S1 Search Strategies). The reference lists of all publications included at the full text review were checked manually. Only English language papers were included.
Study selection
The initial search was performed by one reviewer and updated by another. A second reviewer reviewed all the abstracts in the first search and 30% random selection of the updated searches. All the selected full text articles were reviewed by two people. If any disagreement was not solved through discussion a third reviewer was involved. Studies were included if the subjects were free from T2DM at baseline, over the age of 18 and the screening and recruitment was population based in a community setting and the WHO 1998/9 criteria [26] was used for diagnosis and the outcome of the study included diagnostic yield.
Quality Assessment and Data extraction. We used established guidelines on reporting observational studies [27, 28] to develop our quality assessment tool (Text and Table A in S1 Quality Assessment). Each reviewer scored the selected papers separately. Inter-reviewer agreement achieved in 90%.
Authors (n = 15) were contacted via e-mail for missing data and followed up after 2-3 weeks and unfortunately only five responded. Information on the study design, invitation method, risk stratification, screening steps, age, geographical location, locality of settlement (urban versus rural), were extracted. Prevalence of the diagnosis of T2DM, and those at high risk of diabetes were extracted directly and the response rate to each test was calculated using data available in the article. High risk population were defined as those with impaired glucose regulation: either impaired fasting glucose [6Á1 mmol/l (110 mg/dl) fasting glucose < 7 mmol/l (140mg/dl)] or impaired glucose tolerance [7Á8 mmol/l (140 mg/dl) 2 hours OGTT blood glucose < 11Á1 mmol/ l (200 mg/dl)] or both.
Statistical methods
Outcome measures. We classified the screening strategies into one of three categories based on the number of screening steps or stages employed by individual studies. Studies were classified as a) one-step if participants were invited directly for OGTT without undergoing any pre-screening step, b) two-step if participants were invited for OGTT only after undergoing one intermediate screening assessment to identify those at high risk of diabetes and c) three/four-step if participants were invited for OGTT after undergoing pre-OGTT screening assessments at two or three intermediate stages. The type of test employed at the intermediate steps included administering non-invasive tools such as risk questionnaires or computer risk-scores or invasive techniques (blood test) such as fasting or random glucose to identify at risk individuals.
For each strategy outlined above, we considered four outcomes i) initial response rate; defined as the proportion of people accepted the invitation to a screening study divided by the total number invited, ii) OGTT response rate defined as number responding to OGTT screening invitation divided by the total number invited to OGTT, iii) T2DM yield rate defined as the number of newly diagnosed T2DM cases detected by OGTT divided by total number screened using OGTT and iv) Diabetes and high risk yield rate defined as the combined number of T2DM case and those at high risk of developing diabetes detected at the OGTT divided by total number screened using OGTT.
The response rates were applied to a hypothetical population with 1000 adults to compare the yield for each strategy (one step to multi-step) to demonstrate how the different approaches compare if these strategies were implemented in a community setting.
Random effects model
The number of participants responding to a screening invitation or testing positive for diabetes or at risk of diabetes was assumed to be drawn from a binomial distribution so that each study independently estimated its own probability of response and a positive test. The logit of the response and yield probabilities were assumed to be drawn from a normal distribution and pooled across studies using Bayesian random effects meta-analysis.
The number needed to screen (NNS) to detect one T2DM case or the combined endpoint of "diabetes and high risk" was calculated as the inverse of the respective mean yield rates.
The association between screening outcomes (i.e. response and yield rates) and pre-specified study-level characteristics were explored and reported as response or yield rate ratios through univariate meta-regression. To calculate these rate ratios, studies were classed according to: i) the method of screening invitation or recruitment (postal/letter versus home visit/face-to-face invitation), ii) the pre-OGTT step screening tests (invasive test versus non-invasive test), iii) the developmental index of study's country as defined by the United Nations Development programme http:// hdr.undp.org/en/data (developed versus developing country), and iv) the locality of the screening (urban versus rural). The required rate ratios were defined simply as the pooled response or yield rate in one category of a study-level characteristic (for example method of invitation) divided by the corresponding pooled rate in a second category of study-level characteristic which has been designated as the reference category. For example, in the meta-regression model investigating the association between screening outcomes and method invitation, the response rate ratio was calculated as the pooled response rate in the postal invitation group divided the pooled response rate in the non-postal (home visit or face-to-face) invitation group. The yield rate ratio is defined similarly as the ratio of yield in the postal group to the yield in the non-postal group. All rate ratios were estimated on the log-odds scale to ensure the assumptions underlying the random effects meta-analysis model are applicable. Note that in the meta-regression models, studies were excluded if they provided partial or insufficient information to enable the association between a particular studylevel characteristic and screening outcomes to be investigated. Heterogeneity of outcomes was quantified using the between-study standard deviation in rates on the log-odds scale.
The impact of study quality on pooled OGTT response and yield rates was investigated by restricting the analysis to studies with good quality ratings in a sensitivity analysis (Table A and B in S1 Sensitivity Analysis).
All analyses were carried out using Markov Chain Monte Carlo simulations implemented in the WinBUGS software version 1Á4Á3. [29] Minimally informative prior distributions were placed on parameters so that the analysis results are almost entirely determined by the data (model code is presented in the S1 WinBUGS code: Random affects meta-analysis). 95% credible intervals are presented throughout.
Results

Electronic searches and study selection
The flowchart of study identification and selection has been shown in Fig 1. The search identified 21398 articles, of which 395 were selected for full text review and 72 were included for data extraction. Eleven studies [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] had to be excluded in this stage due to lack of data or incomplete reported data. Remaining 61 articles were from 47 studies as some authors had published their results in multiple articles and we reviewed all these related articles to increase the accuracy of extracted data. Tables 1 and 2 present summary statistics of the remaining 47 studies included in the analysis grouped by the type of screening strategy. Twenty-three (49%) of the included studies were conducted in Europe, 16 studies (34%) in Asia, 4 (8Á5%) in Australia and New Zealand, 2 (4.3%) in the United States of American and another 2 (4.3%) in Africa. The age of participants ranged from 18 to 94 years and about half of the studies were of mixed urban rural location.
Characteristic of included studies
Some studies were excluded from respective outcome analyses as they provided incomplete information on response to OGTT, [41] [42] [43] [44] [45] [46] [47] initial response, [41, 42, [44] [45] [46] [47] [48] [49] [50] and yield for high risk group. [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] Overall, 42 studies were included in the OGTT response rate, 38 in the initial response rate, and 35 in the combined "T2DM and at risk of diabetes" yield analysis.
Twenty-nine (61Á7%) used OGTT alone (one-step screening approach (Table 1) , 11 (23Á4%) used the two-steps screening strategy, three (6Á6%) used a three-step strategy and four (8Á8%) Table 1 . Characteristics of studies conducting a one-step screening strategy using only OGTT. used a four-step strategy. The intermediate strategies in these multi-step approaches included risk score, fasting or random glucose and HbA1c.
Response rates
Estimates of pooled screening response rates are presented in Fig 2. The response rate for OGTT as a proportion of those invited for OGTT was similar in studies using one-step and two-step strategies at approximately 65% and higher in studies using a three/four-step strategy at 85Á4%. Among the studies using a multi-step screening strategy, the response rate to the initial screening invitation was 79Á5% for the two-step strategy which is higher than the estimated 55Á4% response the rate for studies using three/four-step strategy but there was considerable overlap in the uncertainty (i.e. 95% credible intervals) around these estimates (Fig 1) . Only the studies using a three/four-step strategy had an intermediate screening step which had a pooled response rate of 69Á7%.
Positive outcome at initial and intermediate screening stages
The proportion of individuals screened positive (i.e. identified as being at risk of T2DM) at the initial and intermediate stages of the multi-step strategies are summarised in Fig 3. These are the individuals who needed to have the next step of the screening study. The positive outcome rate was similar for two-step and three/four-step at 31.1% and 37.4% respectively at the initial step and remained relatively the same for the intermediate screening step.
Yield rates
Pooled estimates of the yield for T2DM and the high risk (combined endpoint of T2DM and those at high risk of diabetes) are presented in Fig 4. Yield for OGTT T2DM increased from 6Á5% (5Á3, 7Á8) in the one-step to 13Á1% (4Á3, 30Á9) in the two-step and 27Á9% (8Á6, 66Á3) in the three/four-step strategy. These yield rates correspond to number needed to screen with OGTT to detect one case of diabetes of about 15, 7.6 and about 3Á5 persons respectively.
The overall T2DM yield (i.e. the total number of diabetes cases detected at all the steps as a proportion of those screened at the initial step) in the multi-step strategy studies decreased from the 6Á5% in the one-step strategy reported above to 3.6% (2Á6, 4.9) in the two-step strategy and 3Á2% (95% CrI 2Á0, to 5Á1) in the three/four-step strategy. These rates corresponds to an increase in the number needed to screen at the initial step (OGTT if one-step strategy) from 15 in a one-step strategy to 28 and 31 in two-step and three/four-step strategies respectively.
Pooled estimates of the yield for the high risk (the combined endpoint of T2DM and those at high risk of diabetes) were 25Á8% (22Á3, 29Á5), 27.7% (13Á3, 49Á0) and 75Á3% (43Á5, 92Á4) for studies adopting one, two or three/four-step strategies respectively. The number needed to screen to detect one additional person with diabetes or at risk of diabetes was decreased from 4 in a one-step strategy to 3Á5 and 1 in two-step and three/four-step strategies.
We applied the mean response and yield rates from the meta-analysis to a hypothetical population of 1000 individuals in order to determine the diagnostic yield of the three screening strategies (Fig 5) . The number of individuals screened using OGTT decreased from 650 in a one-step strategy to 156 and 45 in two-step and three/four-step screening strategies respectively, and the number of T2DM cases identified decreased from 42 cases in one-step strategy to 28 and 18 in the two-step and three/four-step strategies respectively.
Invasive versus Non-invasive tests
Seven of the 11 studies with a two-step strategy used an invasive test at the first screening step (Table 2 ). There was no evidence that the OGTT response rate was higher in studies using an invasive test than those using a non-invasive test [response rate ratio = 1Á5, (0Á3, 5Á7)]. There was a non-significant increase in the yield for T2DM and combined end point of the T2DM and high risk population in studies using invasive test compared to non-invasive methods [yield rate ratio were 6Á4 (0Á8, 43Á9) and 2Á3 (0Á4, 13Á3) respectively]. To compare the initial response rates one study had to be excluded [19] as a computerised risk score was applied instead of sending participants a risk questionnaire. Among the nine studies, there was no evidence to suggest that the initial screening response differed between invasive and non-invasive screening tests [response rate ratio = 4Á9 (0Á6, 43Á7)].
The effect of invasive versus non-invasive tests on the outcomes of the three/four-step strategies was not investigated as 6 of 7 studies employing this strategy used both invasive and noninvasive tests at the intermediate screening steps.
Other covariate effect and subgroup analyses
Association between screening outcomes and three study-level characteristics: developed versus developing country, invitation method, and urban-rural level are presented in Table 3 . Pooled yield rates from diabetes screening meta-analysis. Estimates are from Bayesian random effects meta-analysis. CrI = Credible intervals which is similar to a confidence intervals generated using Frequentist statistics. NNS* = Number needed to screen at OGTT step to detect one case of type 2 diabetes. NNS** = Number needed to screen at initial screening step (if a multi-step strategy is used) to detect to detect one case of type 2 diabetes. doi:10.1371/journal.pone.0135702.g004
There was no evidence that screening and yield rates were associated with a country's developmental index, the invitation method and the rural or urban location of the community.
Heterogeneity
The estimates of the between-study standard deviation (τ on the log-odds scale presented in S1 Sensitivity Analysis) indicate a high degree of heterogeneity in rates across studies using a one-step, two-step and three/four-step strategies.
Sensitivity analysis
Restricting the analysis to studies assessed as good quality (S1 Quality Assessment) did not substantially alter pooled OGTT response and yield rates. The effect of study quality was not investigated for the initial and intermediate screening outcomes because of insufficient data at these steps.
In result reported above, we specified the following minimally informative prior distributions: i) Normal (0, 10 3 ) for pooled rate on the log-odds scale ii) Uniform (0,100) for the between-study standard deviation. To investigate sensitivity of our results to the choice of prior distributions, we conducted sensitivity analyses for the response and yield outcomes in which Step strategy = Direct invitation to OGTT (Studies in Table 1 ). **Two-Step strategy = One step screen before OGTT (Studies in Table 2 ). ***Three/Four
Step Studies = Two or three screening steps before OGTT (Studies in Table 2 ).
doi:10.1371/journal.pone.0135702.g005
Screening for Type 2 Diabetes we changed the prior distributions to iii) Normal (0, 10 6 ) for the pooled rate and ii) InverseGamma (0.001, 0.001) for the between-study variance. The pooled OGTT response rate was 65.2% (53.2% to 75.8%) for one-step strategy, 63.1% (48.2% to 76.9%) for a two-step strategy and 85.1% (78.8% to 91.7) for a three/four-step strategy. These are very similar to main analysis results (Fig 2) suggesting minimal impact of the prior distributions on the pooled response rates. The sensitivity analyses were repeated for the yield outcomes and meta-regression analyses (results not shown) with the same minimal effect on overall pooled rates.
Discussion
We have summarised and quantified the response and diagnostic yield rates of different screening strategies for T2DM and the high risk population. Our meta-analysis indicates that, for those invited for OGTT screening, the number needed to screen to detect one T2DM case decreases as the number of screening steps increases. We also showed that while the response rates to OGTT invitation is the same for one and two steps screening strategies, the two-step screening study has higher response rate to the initial screening invitation. In the two-step strategies, there was no difference in the response and yield rates whether a blood test was used as the initial screening step or a risk-score. We also showed that the method of invitation did not impact the response rate; whether it was face to face or through post.
The use of risk classification and reclassification is based on the assumption that individuals should be stratified into clinically relevant risk categories and for most risk scores the area under the receiver operating characteristic curve generally range from 0.7 to 0.8, [101] which is seen as an acceptable level of discrimination. Therefore the absolute number of people identified with diabetes or high risk decreases as the number of steps increases (see Fig 3) . However, a reduced number of OGTTs are performed to find a higher proportion of people with T2DM or those at high risk. This is both the result of screening out the low risk population and also the number of people who are not responding in each intermediary steps. Ultimately a pragmatic point is that less people need to have OGTT screening when the screening steps increase. This has been suggested to be the most cost effective method [6, 102] and our study confirms the two step methods has higher initial response rate to invitation, similar response rate to OGTT invitation and higher yield rates.
Comparison with previous studies and recommendations
Screening for a condition is justified only if there is a net benefit in early detection and treatment of the condition as compared to its natural clinical presentation. [103, 104] It has been suggested that T2DM passes this test if a lifestyle intervention is implemented to prevent diabetes in the high risk population. [5, 6] It is argued that universal screening would not be effective or worthwhile, and that populations at risk should be identified and targeted. [105, 106] The impact of screening at population and individual level, costs, type of test to use, and its effectiveness have been highlighted as important factors in decision making [104, 105] . The evidence for management of newly diagnosed diabetes and those at high risk of diabetes for early intervention [107] and prevention [5, [108] [109] [110] [111] is compelling. The ADDITION study demonstrated that when compared to routine care, an intervention to promote target-driven, intensive management of patients with type 2 diabetes detected by screening was associated with modest but significant differences in prescribed treatment and levels of cardiovascular risk factors at five years. [112] The question to answer is the methodology to approach to the screening task. Screening a population using a non-invasive risk stratification tool followed by a definite blood test seems the most cost-effective method of screening for T2DM and those at high risk [6, 102] . Stepwise approach and adding an initial screening test (biochemical or risk score) before the "definitive test" increases the yield from OGTT. Recently National Institute for Clinical Excellence also recommended [6] screening for high risk population and offering blood test for those at high risk of diabetes. Our results confirm this and may have an impact on the cost-effectiveness of this recommendation.
Unfortunately due to lack of qualified studies we were unable to compare screening using different tests such as random or fasting blood glucose, HbA1c, or the risk score as the initial screening step. One study used HbA1c as a screening step [100] . It would also, be ideal if we could report the difference between self-scoring and applied risk score and compare their impact on the response rate to OGTT and overall yield of diabetes. This is the first meta-analysis to determine response and yield rate when screening for T2DM and people at high risk of diabetes. We used a wide terminology in initial searching for the papers to increase the capture of the publications and reduce missing papers. There was a variety of approaches in invitation and steps prior to the final definitive test (OGTT) and this restricted the meta-analysis and subgroup analysis of the data, however we used robust statistical techniques. We only included the English language papers, but made no limitation on the population size and analysed the data for different regions.
Some studies did not clearly report method of invitation, response rate or exact numbers of participants partaking in certain screening steps. However missing data is always a problem in evidence synthesis and we managed to recover some by contacting authors and or re-calculating the outcomes. Another limitation in any evidence synthesis is the fact that all studies are not really and truly the same and combining their results may not be the real reflection of the pooled outcomes. This is reflected in the high level of heterogeneity seen across all outcomes. In our study; the number and order of the tests used before OGTT, impact of the self-score versus computer generated score, differences between different risk scores, possible impact of population dynamic and the psychosocial factors, wording of the invitation letter and its impact on the response to invitation are examples of some of the possible factors which we could not truly account for their effects on our results.
We used OGTT as the definite test for diagnosis of diabetes. Although, the new guidelines [4, 113] suggest the use of HbA1c for the diagnosis of diabetes, they do not exclude the use of OGTT. Besides, some countries will continue to use OGTT as their screening tool. [12] [13] [14] [15] A detailed modelling is necessary to compare the cost-effectiveness of this approach with multistep screening.
Conclusion
We have been able to provide evidence for the overall response rate and yield of diabetes screening in the background of a variety of factors such as geographical area, invitation methods and locality of the population (urban vs. rural) which influences decision making when undertaking this task.
We can conclude that performing a multi-step approach in a population screening increases the yield and decreases the number needed to screen by OGTT and in the two-step approach it even increases the initial response rate to the invitation. In terms of absolute numbers, the highest yield of diabetes, however, is obtained in the one step studies where an OGTT is offered as a screening test to the population. The process of screening for T2DM or those at high risk of diabetes needs careful re-evaluation by local policy makers in each country especially in view of our findings. 
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